Gene · 800
CALD1: caldesmon 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CALD1: caldesmon 1. Genes, record 800. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/800
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q05682 | Caldesmon | 793 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents26
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4641201 A2 | 2025-10-29 | 8038 | Q05682 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 8038 | Q05682 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 10996 | Q05682 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 5238 | Q05682 | Espacenet |
| EP 4373841 A1 | 2024-05-29 | 21 | Q05682 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 10996 | Q05682 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 113967 | Q05682 | Espacenet |
| US 10751370 B2 | 2020-08-25 | 2 | Q05682 | Espacenet |
| WO 2020043864 A1 | 2020-03-05 | 357 | Q05682 | Espacenet |
| US 10501513 B2 | 2019-12-10 | 5238 | Q05682 | Espacenet |
1 to 10 of 26
See all 26 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,614
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CALD1 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 26 | 2025 |
| P50CA217694 | SPORE in Soft Tissue Sarcoma | 12 | 2025 |
| R01HL036153 | Thin Filaments and Muscle Regulation | 11 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 9 | 2025 |
| P30EY016665 | Core Grant for Vision Research | 8 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 5 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 4 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 4 | 2025 |
| P30CA016042 | Cancer Center Support Grant | 3 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,614Source NIH's project files
See all 1,614 nih grantsPapers3,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling the pathogenic mechanisms of osteoarthritis and obesity: An integration of GWAS, cellular specificity, and spatial transcriptomics. | Osteoarthr Cartil Open | 2026 | 42656980 | PubTator, text mining | PubMed |
| Primary hepatic leiomyosarcoma diagnosed after right hepatectomy: A rare case report. | Rare Tumors | 2026 | 42605346 | PubTator, text mining | PubMed |
| An Unusual Presentation of Leiomyosarcoma Mimicking Parasitic Fibroids: A Diagnostic Dilemma. | Cureus | 2026 | 42605333 | PubTator, text mining | PubMed |
| Intimal sarcoma of the heart and great vessels: clinicopathologic series with imaging and immunohistochemistry correlation. | Arch Cardiol Mex | 2026 | 42555972 | PubTator, text mining | PubMed |
| Glioblastoma beyond the Brain: A Case Series Demonstrating Systemic Metastatic Potential. | Case Rep Oncol | 2026 | 42549384 | PubTator, text mining | PubMed |
| Spatial transcriptomic analysis reveals spatial features in human Stanford type A aortic dissection. | iScience | 2026 | 42519065 | PubTator, text mining | PubMed |
| Integrative multi-omics profiling identifies a lactylation-associated, metabolically active, and immunosuppressive subtype of colon adenocarcinoma. | Mol Cell Oncol | 2026 | 42459416 | PubTator, text mining | PubMed |
| Shared Genetic Architecture of Epilepsy and Glioma Revealed by Mendelian Randomization: Identifying Prognostic Biomarkers and Therapeutic Targets. | Curr Cancer Drug Targets | 2026 | 42458946 | PubTator, text mining | PubMed |
| Uterine Leiomyomas Presenting During Pregnancy and Delivery: Comprehensive Characterization of Features Helpful in the Distinction From Malignant Mimics. | Am J Surg Pathol | 2026 | 42452858 | PubTator, text mining | PubMed |
| Porcine submandibular glands as potential salivary gland experimental models: histological, immunohistochemical, and ultrastructural characterization. | J Mol Histol | 2026 | 42446749 | PubTator, text mining | PubMed |
1 to 10 of 3,413
See all 3,413 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/800
GET https://conductscience.org/api/genes/v1/800/patents?page=2